Investor
The new fund is country-agnostic, and it's looking for startups that aim to use digital tools to decrease mortality rates.
Investors have showered the New York company with $876 million to date.
The telehealth brand's annual revenue increased 80% YoY to $148.8 million in 2020, although its quarterly YoY growth dipped in Q4 compared to the months prior.
OMERS Growth Equity and Kaiser Permanente Group Trust led the round, with participation from McKesson Ventures and B Capital Group.
The company said that its platform is tracking more than 325 million patients' healthcare encounters.
The SEC has charged uBiome cofounders with defrauding investors and pushing doctors to order unnecessary medical tests.
This Series B round brings the company's total funding to $223.5 million.
The round was led by Insight Partners Spark Capital, Concord Health Partners and HWVP with participation from KKR, Rivas Capital and Sigmas Group.
Scale Venture Partners and Insight Partners led the financing with participation from Greenoaks, Kleiner Perkins, Threshold Ventures, CRV, Innovation Endeavors and Susa Ventures.
The startup's platform now covers more than 20 million lives and is available worldwide.